Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $128000.0.

  • InspireMD's Depreciation & Amortization (CF) rose 8285.71% to $128000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $408000.0, marking a year-over-year increase of 5338.35%. This contributed to the annual value of $280.0 million for FY2024, which is 2068.97% up from last year.
  • Per InspireMD's latest filing, its Depreciation & Amortization (CF) stood at $128000.0 for Q3 2025, which was up 8285.71% from $107000.0 recorded in Q2 2025.
  • In the past 5 years, InspireMD's Depreciation & Amortization (CF) registered a high of $128000.0 during Q3 2025, and its lowest value of $33000.0 during Q2 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $58000.0 (2023), whereas its average is $64111.1.
  • Per our database at Business Quant, InspireMD's Depreciation & Amortization (CF) plummeted by 1960.78% in 2022 and then skyrocketed by 8285.71% in 2025.
  • InspireMD's Depreciation & Amortization (CF) (Quarter) stood at $37000.0 in 2021, then skyrocketed by 45.95% to $54000.0 in 2022, then rose by 12.96% to $61000.0 in 2023, then rose by 22.95% to $75000.0 in 2024, then surged by 70.67% to $128000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $128000.0 for Q3 2025, versus $107000.0 for Q2 2025 and $98000.0 for Q1 2025.